hydroxychloroquine has been researched along with Anxiety in 7 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Data regarding knowledge and attitude about COVID-19, the prevalence of acceptance of hydroxychloroquine prophylaxis and anxiety amidst COVID-19 pandemic among health care students/professionals in India is scarce." | 7.96 | Knowledge, anxiety and the use of hydroxychloroquine prophylaxis among health care students and professionals regarding COVID-19 pandemic. ( Bansal, AS; Garg, A; Jindal, V; Kaur, G; Kaur, P; Kaur, T; Mittal, S; Sati, HC, 2020) |
| "The study included 105 patients with rheumatoid arthritis who were treated with methotrexate, leflunomide, hydroxychloroquine and biological drugs." | 7.79 | Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. ( Nardi, AE; Ornelas, AC; Pinho de Oliveira Ribeiro, N; Pinho de Oliveira, CM; Rafael de Mello Schier, A; Silva, AC, 2013) |
| "Data regarding knowledge and attitude about COVID-19, the prevalence of acceptance of hydroxychloroquine prophylaxis and anxiety amidst COVID-19 pandemic among health care students/professionals in India is scarce." | 3.96 | Knowledge, anxiety and the use of hydroxychloroquine prophylaxis among health care students and professionals regarding COVID-19 pandemic. ( Bansal, AS; Garg, A; Jindal, V; Kaur, G; Kaur, P; Kaur, T; Mittal, S; Sati, HC, 2020) |
| "The study included 105 patients with rheumatoid arthritis who were treated with methotrexate, leflunomide, hydroxychloroquine and biological drugs." | 3.79 | Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. ( Nardi, AE; Ornelas, AC; Pinho de Oliveira Ribeiro, N; Pinho de Oliveira, CM; Rafael de Mello Schier, A; Silva, AC, 2013) |
| "To perform a systematic review on the psychiatric adverse effects of chloroquine (CQ) and hydroxychloroquine (HCQ); to summarize what is known about psychiatric adverse effects of these drugs; to compare clinical trials, populational studies, and case report studies; and to increase awareness of the potential psychiatric adverse effects of these drugs." | 3.01 | Systematic Review of Psychiatric Adverse Effects Induced by Chloroquine and Hydroxychloroquine: Case Reports and Population Studies. ( Cao, B; Chakravarty, S; Greenshaw, AJ; Liu, YS; Passos, IC; Talarico, F, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Talarico, F | 1 |
| Chakravarty, S | 1 |
| Liu, YS | 1 |
| Greenshaw, AJ | 1 |
| Passos, IC | 1 |
| Cao, B | 1 |
| Cornet, A | 2 |
| Andersen, J | 2 |
| Tani, C | 2 |
| Mosca, M | 2 |
| Shader, RI | 1 |
| Jindal, V | 1 |
| Mittal, S | 1 |
| Kaur, T | 1 |
| Bansal, AS | 1 |
| Kaur, P | 1 |
| Kaur, G | 1 |
| Sati, HC | 1 |
| Garg, A | 1 |
| Pinho de Oliveira Ribeiro, N | 1 |
| Rafael de Mello Schier, A | 1 |
| Ornelas, AC | 1 |
| Pinho de Oliveira, CM | 1 |
| Nardi, AE | 1 |
| Silva, AC | 1 |
| Nashel, DJ | 1 |
| Ulmer, CC | 1 |
1 review available for hydroxychloroquine and Anxiety
| Article | Year |
|---|---|
Systematic Review of Psychiatric Adverse Effects Induced by Chloroquine and Hydroxychloroquine: Case Reports and Population Studies.
Topics: Anxiety; Chloroquine; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; M | 2023 |
6 other studies available for hydroxychloroquine and Anxiety
| Article | Year |
|---|---|
Consequences of medication unavailability on patient anxiety: the example of the 2020 hydroxychloroquine availability crisis for patients with SLE - 18 months later.
Topics: Antirheumatic Agents; Anxiety; Anxiety Disorders; Humans; Hydroxychloroquine; Lupus Erythematosus, S | 2023 |
COVID-19 and Depression.
Topics: Anxiety; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Depression; Humans; Hydroxy | 2020 |
Knowledge, anxiety and the use of hydroxychloroquine prophylaxis among health care students and professionals regarding COVID-19 pandemic.
Topics: Adult; Anxiety; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Female; Health Knowledge | 2020 |
Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety.
Topics: Antirheumatic Agents; Anxiety; Civil Defense; Community Pharmacy Services; COVID-19; COVID-19 Drug T | 2021 |
Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs.
Topics: Adult; Aged; Antirheumatic Agents; Anxiety; Arthritis, Rheumatoid; Comorbidity; Depression; Female; | 2013 |
Systemic lupus erythematosus: important considerations in the adolescent.
Topics: Adolescent; Alopecia; Anxiety; Chronic Disease; Depression; Female; Humans; Hydroxychloroquine; Lupu | 1982 |